Correlation Between AptaBio Therapeutics and Insung Information

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Insung Information at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Insung Information into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Insung Information Co, you can compare the effects of market volatilities on AptaBio Therapeutics and Insung Information and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Insung Information. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Insung Information.

Diversification Opportunities for AptaBio Therapeutics and Insung Information

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between AptaBio and Insung is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Insung Information Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insung Information and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Insung Information. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insung Information has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Insung Information go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Insung Information

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to generate 2.3 times less return on investment than Insung Information. But when comparing it to its historical volatility, AptaBio Therapeutics is 1.06 times less risky than Insung Information. It trades about 0.0 of its potential returns per unit of risk. Insung Information Co is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  244,095  in Insung Information Co on October 5, 2024 and sell it today you would lose (60,695) from holding Insung Information Co or give up 24.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Insung Information Co

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Insung Information 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Insung Information Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

AptaBio Therapeutics and Insung Information Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Insung Information

The main advantage of trading using opposite AptaBio Therapeutics and Insung Information positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Insung Information can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insung Information will offset losses from the drop in Insung Information's long position.
The idea behind AptaBio Therapeutics and Insung Information Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.